𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hematopoietic Stem Cell Gene Therapy

✍ Scribed by David W. Emery; Tamon Nishino; Ken Murata; Michalis Fragkos; George Stamatoyannopoulos


Publisher
Carden Jennings Publishing
Year
2002
Tongue
English
Weight
133 KB
Volume
75
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hematopoietic stem cell gene therapy for
✍ Pamela S. Becker πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

From the time that the genes encoding the defective proteins were cloned for a number of inherited diseases, it became a goal to correct those conditions by restoring the normal gene and thereby, its product. For the inherited disorders affecting the blood and its progenitor cells, the hematopoietic

Post-transduction events in retrovirus-m
✍ Jeffrey A. Medin; Daniel H. Fowler πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 147 KB

Numerous incremental technological improvements have occurred recently in the application of therapeutic retrovirus-mediated gene transfer into hematopoietic stem cells (HSCs). Improved transduction efficiencies are now reaching levels that may correct some inherited or acquired disorders. Novel ret

Partial phenotypic correction and immune
✍ GaΓ«lle Douillard-Guilloux; Emmanuel Richard; Lionel Batista; Catherine Caillaud πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 472 KB πŸ‘ 1 views

## Abstract ## Background Glycogen storage disease type II (GSDII) or Pompe disease is an inherited disease of glycogen metabolism caused by a lack of functional lysosomal acid α‐glucosidase (GAA). Affected individuals store glycogen in lysosomes resulting in fatal hypertrophic cardiomyopathy and